Research on the Mechanism of Qushi Huayu Decoction in the Intervention of Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking Technology

المؤلفون المشاركون

Hu, Yi-Yang
Gao, Shanshan
Sun, Ji-jia
Wang, Xin
Feng, Qin
Gou, Xiao-jun

المصدر

BioMed Research International

العدد

المجلد 2020، العدد 2020 (31 ديسمبر/كانون الأول 2020)، ص ص. 1-12، 12ص.

الناشر

Hindawi Publishing Corporation

تاريخ النشر

2020-11-04

دولة النشر

مصر

عدد الصفحات

12

التخصصات الرئيسية

الطب البشري

الملخص EN

Objective.

To use network pharmacology and molecular docking technology in predicting the main active ingredients and targets of Qushi Huayu Decoction (QHD) treatment in Nonalcoholic Fatty Liver Disease (NAFLD) and explore the potential mechanisms of its multi-component-multi-target-multi-pathway.

Materials and Methods.

The main chemical components of QHD were searched using traditional Chinese medicine system pharmacology technology platform (TCMSP) and PubChem database.

The main chemical components of the prescription were ADMET screened by the ACD/Labs software.

The main active ingredient was screened by 60% oral bioavailability, and 60% of “bad” ingredients were removed from the drug-like group.

Swiss Target Prediction, the SEA, and HitPick systems were sequentially used to search for the target of each active ingredient, and a network map of the QHD’s target of the active ingredient was constructed.

Genome annotation database platforms (GeneCards, OMIM, and DisGeNET) were used to predict action targets related to fatty liver disease.

“Drug-Disease-Target” network diagram could be visualized with the help of Cytoscape (3.7.1) software.

UniProt and STRING database platforms were used to build a protein interaction network.

The KEGG signal pathway and DAVID platform were analyzed for biological process enrichment.

Results.

A total of 128 active ingredients and 275 corresponding targets in QHD were discovered through screening.

55 key target targets and 27 important signaling pathways were screened, such as the cancer pathway, P13K-AKT signaling pathway, PPAR signaling pathway, and other related signaling pathways.

Conclusions.

The present study revealed the material basis of QHD and discussed the pharmacological mechanism of QHD in fatty liver, thus providing a scientific basis for the clinical application and experimental research of QHD in the future.

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

Gao, Shanshan& Sun, Ji-jia& Wang, Xin& Hu, Yi-Yang& Feng, Qin& Gou, Xiao-jun. 2020. Research on the Mechanism of Qushi Huayu Decoction in the Intervention of Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking Technology. BioMed Research International،Vol. 2020, no. 2020, pp.1-12.
https://search.emarefa.net/detail/BIM-1131858

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

Gao, Shanshan…[et al.]. Research on the Mechanism of Qushi Huayu Decoction in the Intervention of Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking Technology. BioMed Research International No. 2020 (2020), pp.1-12.
https://search.emarefa.net/detail/BIM-1131858

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

Gao, Shanshan& Sun, Ji-jia& Wang, Xin& Hu, Yi-Yang& Feng, Qin& Gou, Xiao-jun. Research on the Mechanism of Qushi Huayu Decoction in the Intervention of Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking Technology. BioMed Research International. 2020. Vol. 2020, no. 2020, pp.1-12.
https://search.emarefa.net/detail/BIM-1131858

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references

رقم السجل

BIM-1131858